We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
678

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.15%
2 Financials 9.51%
3 Healthcare 7.52%
4 Consumer Discretionary 6.79%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KD icon
5201
CALL
Kyndryl
KD
$2.73B
-28,700
Closed -$281K
KEY icon
5202
PUT
KeyCorp
KEY
$23.3B
-170,000
Closed -$2.93M
KITT icon
5203
Nauticus Robotics
KITT
$6.56M
-329
Closed -$8.6M
KLIC icon
5204
PUT
Kulicke & Soffa
KLIC
$4.49B
-65,200
Closed -$2.79M
KNX icon
5205
PUT
Knight Transportation
KNX
$11.7B
-40,200
Closed -$1.86M
KROS icon
5206
Keros Therapeutics
KROS
$219M
-21,056
Closed -$582K
LCTX icon
5207
Lineage Cell Therapeutics
LCTX
$273M
-10,886
Closed -$17K
LEA icon
5208
Lear
LEA
$8.56B
-12,200
Closed -$1.54M
LEA icon
5209
PUT
Lear
LEA
$8.56B
-39,600
Closed -$4.99M
LFST icon
5210
Lifestance Health
LFST
$4.76B
-27,787
Closed -$154K
LFVN icon
5211
LifeVantage
LFVN
$84.4M
-47,415
Closed -$206K
LIDR icon
5212
AEye
LIDR
$59M
-2,070
Closed -$119K
LNTH icon
5213
Lantheus
LNTH
$6.53B
-223,862
Closed -$17M
LPL icon
5214
LG Display
LPL
$3.28B
-82,285
Closed -$459K
LPSN icon
5215
CALL
LivePerson
LPSN
$34.9M
-1,633
Closed -$346K
LQDA icon
5216
Liquidia Corp
LQDA
$6.14B
-478,155
Closed -$2.08M
LRN icon
5217
Stride
LRN
$3.51B
-350,411
Closed -$14.3M
LSF icon
5218
Laird Superfood
LSF
$42.2M
-10,346
Closed -$20K
SEGG
5219
Sports Entertainment Gaming Global Corp
SEGG
$8.15M
-69
Closed -$109K
LWLG icon
5220
Lightwave Logic
LWLG
$954M
-77,951
Closed -$510K
LXU icon
5221
CALL
LSB Industries
LXU
$801M
-32,000
Closed -$444K
MASI
5222
PUT
DELISTED
Masimo
MASI
-3,300
Closed -$431K
MATV icon
5223
Mativ Holdings
MATV
$688M
-57,168
Closed -$1.44M
MAX icon
5224
MediaAlpha
MAX
$793M
-18,504
Closed -$182K
MCRB icon
5225
Seres Therapeutics
MCRB
$45.8M
-2,157
Closed -$148K

Similar funds

David Shaw's Q3 2022 Portfolio in Review

As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, David Shaw opened a new position in Prologis worth $66.1M.

  • David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
  • David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • David Shaw opened 545 new positions and closed 678 in Q3 2022.
  • David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.